Skip to content

Good eyesight of middle-aged and old eye patch alleviate symptoms of dry eye: a randomized parallel, double blind, placebo controlled, multicenter clinical trial

Good eyesight of middle-aged and old eye patch alleviate symptoms of dry eye: a randomized parallel, double blind, placebo controlled, multicenter clinical trial

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900023593
Enrollment
Unknown
Registered
2019-06-03
Start date
2019-06-05
Completion date
Unknown
Last updated
2019-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dry eyes

Interventions

The experimental group (good eyesight middle-aged and old eye patch):Two times a day (nap and night before going to bed), close your eyes, will apply eye patch on the eye, every 15 minutes
The control group (good eyesight middle-aged and old eye patch simulation agent):The control group (good eyesight middle-aged and old eye patch simulation agent)

Sponsors

China-Japan Friendship Hospital, Xiamen University Affiliated Eye Center
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) signed informed consent; (2) aged 40 to 80 years; (3) light, moderate patients with dry eye, that is, at the same time satisfy the 2 s < BUT 10 s, or less 2 mm / 5 min < Schirmer I 10 mm / 5 min or less fluorescein staining point is less than 5 shaded; (4) not to use or stop using artificial tears more than 1 week. Note: each subject in the study only included in the eye, such as eyes, observing the heavier the eye, such as eyes condition is the same watch the right eye.

Exclusion criteria

Exclusion criteria: (1) the merger keratitis and conjunctivitis and other serious ocular surface diseases that affect curative effect evaluation; (2) the eye lesions or swelling; (3) the eye surgery under six months; (4) with heart, liver, kidney and hematopoietic system and so on patients with severe primary diseases and systemic autoimmune disease; (5) pregnancy, nursing mothers; (6) the skin allergy and allergic to test products contain ingredient; (7) for nearly one month participated in other clinical subjects; (8) the patient can't cooperation or psychiatric patients, the researchers think/her unsuitable to participate in this clinical subjects.

Design outcomes

Primary

MeasureTime frame
Vision (naked eye eyesight, vision correction);Tear secretion test (Schirmer I);It appears burst time (BUT);Fluorescein staining scores;Intraocular pressure testing;Urine pregnancy test;

Countries

China

Contacts

Public ContactQiuxia Zhang
zhangqiuxia@xinsm.com+86 13837151676

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026